AI in Healthcare Daily Digest

Executive Brief The inaugural State of Clinical AI Report — a synthesis of the most significant clinical AI research from 2025 — draws a hard line between what performs in controlled studies and what holds up when deployed in real clinical environments. The gap is wider than the field has acknowledged.

Executive Brief A new survey finds that 76% of U.S. health systems now have formal precision medicine programs — up sharply from prior years — with AI automation eliminating the manual, labor-intensive variant-to-treatment matching process that previously bottlenecked genomic medicine.

Executive Brief Merck and Mayo Clinic have formalized a joint R&D agreement that pairs Mayo's multimodal clinical and genomic datasets with Merck's AI virtual cell technologies — one of the largest pharma-health system collaborations focused on AI-driven drug discovery to date.

Executive Brief A new AI architecture that jointly analyzes histopathology slides and radiological imaging — two data streams that have historically been interpreted in separate clinical siloes — demonstrates significantly improved diagnostic accuracy over either modality alone.

Executive Brief Aidoc received FDA clearance for 14 acute care indications powered by a single AI foundation model — the first time the FDA has cleared double-digit indications from one underlying model architecture, marking a regulatory breakthrough for foundation model deployment in radiology.

Executive Brief New FDA guidance issued in January 2026 removes regulatory oversight from a broad class of clinical decision support software and consumer wearables, creating a faster path to market for low-risk AI health tools while concentrating scrutiny on high-risk applications.

Executive Brief The Trusted Exchange Framework and Common Agreement (TEFCA), America's national health data interoperability network, has crossed 500 million records exchanged — and HHS is now actively deploying AI on top of that data infrastructure to reduce administrative cost and care burden.

Executive Brief Digital health funding surged to $7.4B in Q1 2026 — a 25% jump from Q4 2025 — fueled by AI drug discovery mega-rounds and an M&A market returning to pre-2022 activity levels. Eight new unicorns were minted in the quarter, the highest single-quarter count in nearly four years.

Executive Brief Jimini Health closed a $17M seed round to launch Sage, an AI chatbot designed for complex mental health care — targeting large behavioral health organizations rather than direct-to-consumer users, a strategic positioning that bets on institutional distribution over consumer acquisition.

Executive Brief Marvin AI announced two major health system partnerships that expand its behavioral health platform to more than 45,000 healthcare workers across 10 states — positioning clinician mental health support as a distinct AI market category separate from patient-facing care tools.

Executive Brief Tucuvi closed a $20M Series A to scale its AI voice agent platform for post-acute and chronic disease care management — targeting the gap between hospital discharge and next clinical contact where patients are most likely to deteriorate and most likely to be unreachable.

Executive Brief A pointed analysis argues that venture capital is systematically overweighting AI drug discovery and large health system pilots while missing the highest-value category opportunities in community and post-acute care — where AI has the clearest ROI case and the least competition.

Executive Brief A widely circulated U.S. News piece captures the dominant anxiety in healthcare AI conversations right now: patient trust and data privacy. As AI moves deeper into clinical workflows, patients — and their physicians — are increasingly asking who owns the data AI learns from and what happens when it gets it wrong.

Executive Brief A widely shared MedCity News opinion piece argues that healthcare's fixation on AI documentation and ambient scribes is addressing physician convenience while systematically ignoring the nursing workforce crisis — where 250,000+ vacancies are driving patient care failures that no AI tool currently deployed can address.

Executive Brief STAT's most-read health tech piece of the year frames the central unresolved question of healthcare AI in 2026: reimbursement. Hospitals are deploying AI without a clear payment model; payers are watching; and CMS has not moved on coverage for the majority of cleared AI tools.